Jim joined 5AM Ventures in 2006 as a Venture Partner. Dr. Young has been involved with Sunesis since 2000, as Chief Executive Officer, Executive Chairman and currently as Chairman. Prior to Sunesis, Jim was Senior Vice President, Research and Development and Group Vice President at ALZA Corporation. Before joining ALZA, Jim was President of the Pharmaceuticals Division of Affymax, N.V., and Senior Vice President and General Manager of the Pharmaceuticals Division at Sepracor. Previously, Jim was Vice President of Research at Zoecon/Sandoz Crop Protection Corporation. He is currently a Director of Chrono Therapeutics and Portal Instruments. Jim served as Executive Chairman and then as a Director of Pearl until its acquisition by AstraZeneca. He was also a Director of Incline (acquired by The Medicines Company). Jim earned a B.S. in Chemistry from Fordham University and a Ph.D. in Organic Chemistry from Cornell University. Jim is based in the San Francisco, CA office.